IMAGINING FUTURE PRODUCTS
Innovation> Read more
Amounts allocated to R&D reflect the importance that we attach to the discovery and development of innovative therapeutic and well-being solutions, from health to beauty. Pierre Fabre combines pharmaceuticals research and dermocosmetics research, thus creating novel links between these different fields. The Group makes use of cross-functional expertise, in particular, research on plants and expert knowledge on active ingredients of natural or biotechnological origin.
The development of a pharmaceuticals drug is a long and complex process, which on average takes 15 years, requiring 10,000 synthesized molecules to market one drug. To rise to this challenge, Pierre Fabre R&D relies on 5 main areas of expertise.
INNOVATION IN DERMO-COSMETICS
To enhance our offer of dermo-cosmetics products, our researchers are identifying new active ingredients of natural, biological or chemical origin and exploring the cutaneous and capillary mechanisms on a tissue, cellular and molecular scale. They are focusing on 7 lines of research and 6 areas of scientific expertise.
DEVELOPING AND INNOVATING TOGETHER
SHARING> Read more
We have always favored a partnershipbased approach, convinced that synergy and sharing of expertise are business and innovation accelerators. 30 years after our first historic partnership agreement with the CNRS, we are continuing our collaboration with French public research bodies (Teaching Hospitals, INSERM, etc.), universities (École polytechnique de Lausanne, Université de Saclay, etc.), biotech companies (Array BioPharma, AbCheck, Cellectar, etc.) and international pharmaceuticals laboratories (Allergan, Abbvie, etc.). In 2015, we wanted to go further by launching two major open innovation initiatives.
NATURE OPEN LIBRARY
With the launch of Nature Open Library in 2015, we would like to share our expertise in the research, development and industrialization of plant-based active ingredients with private and public players heading innovative projects.
Pierre Fabre Fund for innovation
With the Pierre Fabre Fund for Innovation initiative, we are enabling biotechs, start-ups and research laboratories (public and private) to speed up the clinical development of their molecules at the advanced stage of research or at the early stage of clinical development.
EXPLORING THE BEST OF NATURE
Inspiration> Read more
A source of inspiration, exploration and beauty, nature is at the heart of our development model. Research into natural substances is a historic and original focus for our Laboratories. For over half a century, we have been convinced that nature still holds undiscovered benefits for healing, soothing and beautifying.
MANUFACTURING IN COMPLIANCE WITH THE STRICTEST STANDARDS
Rigor> Read more
We have chosen to internalize the design and manufacture of most of our products, from research to distribution, to guarantee quality by controlling the entire logistics chain. Our manufacturing applies innovative processes, based on a progress initiative, which constantly raises the standards and the overall level of quality.
- Cytotoxic molecules and production in aseptic conditions
- Hard-boiled pharmaceuticals lozenges
- Pharmaceuticals in dry, paste and liquid forms
- Paste forms and toothpastes
- Sterile Cosmetics and Dermo-Cosmetics
- Active ingredients
(Contract Development and Manufacturing Organization)
The Pierre Fabre CDMO teams offer their international partners a wide range of innovative solutions for their pharmaceutical projects.
- Injectable products, for conventional cytotoxic agents and products from biotechnology
- Lozenges in a pharmaceuticals environment
- Tablets, liquids and creams
- Active ingredients, in particular natural active ingredients
PROVIDING SUPPORT, FROM PRESCRIPTION TO ADVICE
ATTENTIVENESS> Read more
The Pierre Fabre Group is committed to improving the treatment, health and well-being of patients and consumers.
To carry out this mission, we form partnerships based on trust all over the world and at home with health care professionals who are in the best position to prescribe or recommend the Group’s products. They know their patients’ needs and can provide them with the information required for the correct use of our products better than anyone else.
ADDRESSING PUBLIC HEALTH CHALLENGES
PREVENTION> Read more
The comprehensive treatment of patients also requires educational and preventive measures. In order to do this, we are developing programs that support the work of health care professionals. Our goal: to ensure that the health of patients suffering from severe or chronic pathologies is not worsened, and to help healthy individuals stay in good health.
- Preventing skin cancer
- Smoking cessation
- Prevention in oral care
- Adapted Physical Activity (APA)